Viewing Study NCT02159950


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-02-21 @ 6:01 AM
Study NCT ID: NCT02159950
Status: COMPLETED
Last Update Posted: 2023-04-27
First Post: 2014-06-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Sponsor: Roswell Park Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: I 250813
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View